Gastrointestinal Cancer News

The role of screening in the prevention of colorectal cancer is an “important” issue that is increasingly being recognized among health care systems in the United States, according to Jimmy J. Hwang, MD, of the Levine Cancer Institute.

Researchers recently developed the ITA.LI.CA prognostic system, which accurately predicted survival of Italian and Taiwanese patients with hepatocellular carcinoma, using data from the Italian Liver Cancer database. Further, the system may also serve as a potential use for designating treatment.

New research suggests that cholesterol levels influence colorectal cancer risk, not statin use as identified in previous studies. According to investigators, “indication bias” may explain the associations previously found between statins and reduced risk for colorectal cancer.

NEW ORLEANS — Two species of bacteria linked to periodontal disease may increase the risk for pancreatic cancer, according to results of a nested case–control study presented at the American Association for Cancer Research Annual Meeting.

HemOnc Today presents this guide to drugs in phase 2 or phase 3 development for pancreatic cancer. Clinicians can use this chart as a quick reference to learn about the status of those drugs that may be clinically significant to their practice.

NEW ORLEANS — An investigational agent designed to target the RAF family of proteins demonstrated clinical activity in patients with cancer who harbored BRAF, KRAS or NRAS mutations, according to findings presented at the American Association for Cancer Research Annual Meeting.

In this video with Healio.com, Samir Gupta, MD, of the University of California, San Diego School of Medicine reviews the methods available for colon cancer screening other than colonoscopy.

Patients with sessile serrated adenomas or polyps and traditional serrated adenomas have an increased risk for developing colorectal cancer, according to the results of a nationwide, Danish population-based, case-control study.

In a new study published in the Journal of Clinical Oncology, hepatocellular carcinoma incidence rates in Hispanics and blacks are expected to increase in the U.S. through 2030.

A redesign of the cancer research enterprise is necessary to accelerate advances and achieve 10 years’ worth of progress in 5 years, Vice President Joe Biden said today during the plenary session of the American Association for Cancer Research Annual Meeting.